Data from EMC - Curated by Toby Galbraith - Last updated 10 August 2017

Licensing authority

EMA (European Medicines Agency)


Infanrix hexa is indicated for primary and booster vaccination of infants and toddlers against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and disease caused by Haemophilus influenzae type b.

Full Prescribing information

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.


See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Visit Transplantation

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

Visit Chronic Spontaneous Urticaria (CSU)

Related Content

More information

Category Value
Agency product number EMEA/H/C/000296
Orphan designation No
Date First Approved 23-10-2000
Type Medicinal product subject to medical prescription
Marketing authorisation holder GlaxoSmithKline Biologicals S.A.